These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3435650)

  • 1. [Prevalence of anti-LAV/HTLV III antibodies in groups at risk of infection and in donors blood in the province of Catania].
    Mauro L; Ciccia M; Romeo MA; Di Gregorio F; Sciacca S; Maccarrone S
    Boll Ist Sieroter Milan; 1987; 66(3):194-7. PubMed ID: 3435650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-I and HIV-I antibody frequency in thalassemics and drug addicts in southeast Sicily.
    Gulisano G; Ciccia M; Ienna M; Cipolla A; Mauro L
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):531-4. PubMed ID: 1670058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing prevalence of HTLV-III infection in intravenous drug users in Liguria, Italy.
    Cuneo Crovari P; Terragna A; Robert L; Orlando G; Rizzo F; Piuma-Fusco M; Icardi GC; Papa D; Di Ponzio A; Auteri G
    Boll Ist Sieroter Milan; 1985; 64(4):339-42. PubMed ID: 3000406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies to HIV-infection among high risk groups in Bihar (India).
    Gupta AK; Saran R
    Indian J Public Health; 1993; 37(2):54-6. PubMed ID: 8138289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
    Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for seroprevalence of HTLV-III/HIV infection in high risk groups in Delhi.
    Kumari S; Rai A; Chattopadhya D; Khare S; Ichhpujani RL; Sehgal PN
    J Commun Dis; 1986 Jun; 18(2):77-80. PubMed ID: 3805683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.
    Khameneh ZR; Baradaran M; Sepehrvand N
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular epidemiology of TT virus in Italy and phylogenesis of viral isolates from subjects at different risk for parenteral exposure.
    Zehender G; Manzin A; De Maddalena C; Colasante C; Solforosi L; Corsi F; Bianchi-Bosisio A; Girotto M; Schirru I; Russo U; Galli M; Clementi M
    J Med Virol; 2001 Jan; 63(1):76-84. PubMed ID: 11130892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of dual presence of antibodies to HIV1 and HIV2 in seropositive cases seen in Ibadan, Nigeria.
    Shokunbi WA; Saliu I; Essien EM
    Afr J Med Med Sci; 1995 Sep; 24(3):249-53. PubMed ID: 8798960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy.
    Zanetti AR; Ferroni P; Colombo M; Cargnel A; Mari D; Zehender G; Rumi MG; Gringeri A; Ammassari M; Mannucci PM
    Ric Clin Lab; 1985; 15(4):357-64. PubMed ID: 3914699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
    Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
    Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rate of human herpesvirus-8 seroprevalence in thalassemic patients in Italy.
    Cottoni F; Santarelli R; Gentile G; Gallisai D; Capobianchi A; Masala MV; Montesu MA; Coinu M; Piras D; Martino P; Girelli G; Satta R; Cerimele D; Frati L; Faggioni A; Angeloni A
    J Clin Virol; 2004 May; 30(1):106-9. PubMed ID: 15072763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-I in HIV seropositive Indian blood donors.
    Malhotra VL; Lakshmy A
    J Commun Dis; 1996 Dec; 28(4):270-2. PubMed ID: 9057451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anti-LAV/HTLV-III in Portuguese drug addicts and hemodialyzed patients.
    Lecour H; Santos Ferreira M; Lourenço M; Pestana M; Seara A; Cerqueira Magro F; Fernandes S; Loureiro A; Amaral I; Rodrigues A
    Chemioterapia; 1987 Jun; 6(2 Suppl):635-6. PubMed ID: 3509511
    [No Abstract]   [Full Text] [Related]  

  • 19. AIDS and haemophilia.
    Bloom AL
    Biomed Pharmacother; 1985; 39(7):355-65. PubMed ID: 3938297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.